AVEO Pharmaceuticals, Inc. (AVEO): Consensus Estimates and Trading Data

In the past 52-week period, shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) have moved within the range of $0.50 to $4.24. On the stock’s most recent trading day, the company’s shares ended the regular session at $3.06, which is 27.83% higher than its 52-week high.

AVEO Pharmaceuticals, Inc. (AVEO) has demonstrated a 20-day simple moving average (SMA) of 2.31%, and a 50-day SMA of -9.67%. This public company’s current market capitalization stands at $361.10 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

When thinking about buying shares in a public company, it is useful to gauge the average enthusiasm level of Wall Street analysts for that specific stock. According to the latest data, the consensus recommendation for AVEO Pharmaceuticals, Inc. (AVEO) is Outperform.

When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, AVEO Pharmaceuticals, Inc. (AVEO) delivered a 16.11% surprise with its net revenue.

Ownership at AVEO Pharmaceuticals, Inc. (AVEO), According to Most Recent SEC Filings

Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. AVEO Pharmaceuticals, Inc. (AVEO) has 0 billion shares outstanding currently, 50.91% of which belong to institutional investors. Those institutional holdings amount to $0.18 billion.

Additionally, according to the most recent 13F filing from AVEO Pharmaceuticals, Inc. (AVEO), there were 19 new positions totaling 5,566,287 shares of the company’s stock. There were 11 sold out positions, on the other hand, totaling 4,253,869 shares.

Short, Medium and Long Term Indicators

By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. AVEO Pharmaceuticals, Inc. (AVEO) has had a 20-day average volume of 1,989,815 shares, with an average of 20% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 2,984,046 shares, with an average of 75% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 4,924,338 shares with 0% of long-term indicators pointing to Hold.